First France-India Healthcare Summit to focus on innovation and business opportunities in the growing medical device, E-Health, HealthTech and Health administration sectors
This summit will bring together leading professionals, scientists, star-uppers, trade representatives and medical sector entrepreneurs for 2 days of exchange and conference in Paris centered around opportunities in the French and Indian healthcare sectors.
Paris, France – 7 February 2017 – Two days to discover and exchange between India and France, to learn from each other, to look for shared opportunities, and to build business to business partnerships in the Healthcare Sector, medical devices and E-Health.
Two exclusive days for Indian and French enterprises in healthcare. With the latest scientific breakthrough in the fields of medical devices, personalized medicine, e-Health, and Rare Diseases.
4 Round tables: Medical devices / Innovative management / Rare Diseases / Personalized Medicine.
5 Networking & BtoB moments
6 Keynote speakers, with their latest breakthrough
12 CEO / Founders
22 Exhibition stands
When? 1st & 2nd of March 2017, preceded by a VIP dinner on the 28th of February with investors, entrepreneurs and decision makers.
Where? Biocitech, Technologic Park in Romainville/Paris – 102 avenue Gaston Roussel – Metro Raymond Queneau
Program: to download the full program, visit https://www.healthcare-summit.org/wp-content/uploads/2017/02/france_india-healthcare-summit-2017final.pdf
General registration: To register for the France-India Healthcare Summit, visit https://www.healthcare-summit.org/healthcare-summit/
Media registration: For more information about the France-India Healthcare Summit, or for complimentary Media Registration, please contact Alexia Decarme, firstname.lastname@example.org
About the France-India Healthcare Conference
The France-India Healthcare Conference is a bi-continental Connected Health Conference, that aims to bridge the growing healthcare sectors in France and in India. The conference features leading industry professionals for key notes, workshops and roundtable as well as multiple networking events allowing participants to get the most out of their time in France.
The French-American Consulting Firm aims to develop Bio & Medical Technologies projects across India, USA & France. DECCS will serve purposely your international and European strategies to meet the market and find the suitable investors. Inspired by concepts such as the frugal innovation, DECCS’ team is expert of the Indian biomedical and healthcare sectors. www.deccs.eu
About Medicen Paris Region
Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With nearly 300 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe’s leading health cluster. It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:
- Foster the emergence, development and funding of certified collaborative projects in the healthcare sector, in order to create economic value and jobs
- Increase the international development of innovative startups and SMEs
- Strengthen the attractiveness of the Paris region, which represents more than 50% of life sciences activity in France
Since the creation of the cluster in 2005, 57 innovative products have been launched in the imaging, medical devices and biological tools sectors. The cluster has certified 289 projects. They received funding from the French government (French Inter-Ministry Fund FUI, Structuring Projects fund), the public investment bank Bpifrance, the National Research Agency, the European Regional Development Fund, the Investments for the Future program and/or local authorities, and the Paris region. Total investment is close to €1.2 billion and €533 million of public aid. www.medicen.org